Form 4: Definitive Healthcare EVP Granted 631,068 RSUs

Definitive Healthcare's EVP, Chief Data Officer Benjamin Graboske, was granted 631,068 restricted stock units, vesting over time.

Summary

• Benjamin Graboske, EVP, Chief Data Officer of Definitive Healthcare Corp. (DH), was granted 631,068 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• The RSUs will vest, with 25% vesting on March 1, 2027, followed by subsequent vesting of 6.25%.
• Following this transaction, Mr. Graboske beneficially owns 1,312,026.654 shares of Class A Common Stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine, slightly positive event. It indicates executive retention and alignment with shareholder interests, without revealing any new operational or financial performance data.

Positives

• The grant of 631,068 RSUs to a key executive, Benjamin Graboske, aligns his interests with long-term shareholder value.
• RSUs are a common form of equity compensation, often used to retain and incentivize senior management.

Negatives

• The future vesting schedule means these shares are not immediately available, and their value is tied to the future stock performance.
• The grant dilutes existing shareholders, though the impact from a single executive's grant is typically minor.

Future Outlook

The vesting schedule extending to March 1, 2027, and beyond implies a long-term commitment from the executive to the company's future performance.

Industry Context

StockSavvy.ai notes that equity grants, particularly RSUs, are a standard practice in the healthcare technology sector to attract and retain top talent. This grant to the EVP, Chief Data Officer, underscores the importance of data strategy and innovation within Definitive Healthcare, a common theme among data-driven healthcare platforms.

Comparison to Industry Standards

• Equity compensation packages for senior executives in the healthcare technology sector, such as those at competitors like IQVIA Holdings Inc. or Veeva Systems Inc., often include substantial RSU grants designed to align executive incentives with long-term shareholder value creation.
• The size of this grant for an EVP at Definitive Healthcare appears consistent with industry practices for retaining key leadership in a competitive talent market.

Stakeholder Impact

• Shareholders: Minor dilution from the RSU grant, but potential long-term benefit from executive retention and incentivization.
• Employees: May signal stability and commitment to executive leadership.

Next Steps

• The RSUs will begin vesting on March 1, 2027, with subsequent vesting of 6.25% periodically thereafter.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (an RSU grant) and does not contain information that would fundamentally alter the investment thesis for Definitive Healthcare Corp. It primarily indicates executive retention and alignment, which is generally positive but not a catalyst for a strong buy or sell recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Definitive Healthcare Corp., DH, Form 4, Restricted Stock Units, RSUs, Executive Compensation, Insider Transaction, Benjamin Graboske, Equity Grant, Beneficial Ownership